Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Extracorporeal membrane oxygenation
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Use in COVID-19 patients=== Beginning in early February 2020, doctors in [[COVID-19 pandemic in China|China]] increasingly used ECMO as an adjunct support for patients presenting with acute viral pneumonia associated with [[Severe acute respiratory syndrome coronavirus 2|SARS-CoV-2]] infection ([[COVID-19]]) when, with [[Artificial ventilation|ventilation]] alone, the blood oxygenation levels still remain too low to sustain the patient.<ref name=":0">{{Cite web|url=http://www.xinhuanet.com/english/2020-02/15/c_138785933.htm |archive-url=https://web.archive.org/web/20200216094732/http://www.xinhuanet.com/english/2020-02/15/c_138785933.htm |url-status=dead |archive-date=February 16, 2020 |title=30 to 39 pct of severe COVID-19 patients discharged from Wuhan hospitals: official |website=[[xinhuanet.com]] |access-date=2020-02-16}}</ref> Initial reports indicated that it assisted in restoring patients' blood oxygen saturation and reducing fatalities among the approximately 3% of severe cases where it was utilized.<ref>{{Cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html|title=2019 Novel Coronavirus (2019-nCoV)|last=CDC|date=2020-02-11|website=Centers for Disease Control and Prevention|language=en-us|access-date=2020-02-16}}</ref> For critically ill patients, the mortality rate reduced from around 59β71% with conventional therapy to approximately 46% with extracorporeal membrane oxygenation.<ref>{{cite journal | vauthors = Melhuish TM, Vlok R, Thang C, Askew J, White L | title = Outcomes of extracorporeal membrane oxygenation support for patients with COVID-19: A pooled analysis of 331 cases | journal = The American Journal of Emergency Medicine | volume = 39 | pages = 245β246 | date = January 2021 | pmid = 32487460 | pmc = 7256518 | doi = 10.1016/j.ajem.2020.05.039 |issn=0735-6757 | doi-access = free }}</ref> A March 2021 ''[[Los Angeles Times]]'' cover story illustrated the efficacy of ECMO in an extremely challenging COVID patient.<ref>{{Cite news | newspaper = LA Times | vauthors = Curwen T |title=She was dying of COVID-19. Her last hope was a device that would save or kill her | date = 3 March 2021 |url= http://enewspaper.latimes.com/infinity/article_share.aspx?guid=3ad3b194-c519-46b6-9de0-572e06df5fd3}}</ref> In February 2021, three pregnant Israeli women who had "very serious" cases of COVID-19 were given ECMO treatment and it seemed this treatment option would continue.<ref name="sbnp">{{cite news | vauthors = Ben-Nun S |title=Pregnant women must not get COVID vaccine in first trimester - Health Min. |url=https://www.jpost.com/israel-news/pregnant-women-must-not-get-covid-vaccine-in-first-trimester-health-min-657083 |publisher=The Jerusalem Post |date=4 February 2021}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)